[Chemotherapy of so-called atypical mycobacterioses].
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D051379:Mice; D009164:Mycobacterium Infections / Q000188:drug therapy*; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D011817:Rabbits; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use
D000995:Antitubercular Agents; D010670:Phenylthiourea; D004977:Ethambutol; D003622:Dapsone; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D013307:Streptomycin
Chemotherapie sogenannter atypischer Mycobakteriosen.